FK-409

N/A

Report date: 2023/02/11 20:37:39

NME

Base Information

Drug NameFK-409

Drug Alias NameFK-409FR-900409

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNitric oxide donorsEarly Growth Response Protein 1 inhibitors

TargetsEarly Growth Response Protein 1

Therapy Area/IndicationsHypertensionAngina Pectoris

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsHypertensionAngina Pectoris

ATC CodeN/A